Whole-exome sequencing in the clinic: Lessons from six consecutive cases from the clinician's perspective

Amber Volk, Erin Conboy, Beverly Wical, Marc Patterson, Salman Kirmani

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Whole-exome sequencing (WES) is being used clinically to diagnose rare Mendelian disorders, especially when standard tests have failed. The diagnostic yield from WES is reported to be ∼15-30%; however, data regarding the clinical utility and interpretative challenges from the clinician's perspective are lacking. Here, we present a series of the first 6 unselected consecutive cases seen over a period of 6 months where WES was employed in clinical labs via trio-based testing (proband and parents). While we do not discount the value of WES in the clinical setting, our cases and experience illustrate the significant clinical challenges of WES, even when a diagnosis may be achieved.

Original languageEnglish (US)
Pages (from-to)23-31
Number of pages9
JournalMolecular Syndromology
Volume6
Issue number1
DOIs
StatePublished - Mar 6 2015

Fingerprint

Exome

Keywords

  • Diagnostic odyssey
  • Schinzel-Giedion syndrome
  • Whole-exome sequencing

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Whole-exome sequencing in the clinic : Lessons from six consecutive cases from the clinician's perspective. / Volk, Amber; Conboy, Erin; Wical, Beverly; Patterson, Marc; Kirmani, Salman.

In: Molecular Syndromology, Vol. 6, No. 1, 06.03.2015, p. 23-31.

Research output: Contribution to journalArticle

Volk, Amber ; Conboy, Erin ; Wical, Beverly ; Patterson, Marc ; Kirmani, Salman. / Whole-exome sequencing in the clinic : Lessons from six consecutive cases from the clinician's perspective. In: Molecular Syndromology. 2015 ; Vol. 6, No. 1. pp. 23-31.
@article{e1dd3460c9824a4d9ffd7d4ec51ed4d9,
title = "Whole-exome sequencing in the clinic: Lessons from six consecutive cases from the clinician's perspective",
abstract = "Whole-exome sequencing (WES) is being used clinically to diagnose rare Mendelian disorders, especially when standard tests have failed. The diagnostic yield from WES is reported to be ∼15-30{\%}; however, data regarding the clinical utility and interpretative challenges from the clinician's perspective are lacking. Here, we present a series of the first 6 unselected consecutive cases seen over a period of 6 months where WES was employed in clinical labs via trio-based testing (proband and parents). While we do not discount the value of WES in the clinical setting, our cases and experience illustrate the significant clinical challenges of WES, even when a diagnosis may be achieved.",
keywords = "Diagnostic odyssey, Schinzel-Giedion syndrome, Whole-exome sequencing",
author = "Amber Volk and Erin Conboy and Beverly Wical and Marc Patterson and Salman Kirmani",
year = "2015",
month = "3",
day = "6",
doi = "10.1159/000371598",
language = "English (US)",
volume = "6",
pages = "23--31",
journal = "Molecular Syndromology",
issn = "1661-8769",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Whole-exome sequencing in the clinic

T2 - Lessons from six consecutive cases from the clinician's perspective

AU - Volk, Amber

AU - Conboy, Erin

AU - Wical, Beverly

AU - Patterson, Marc

AU - Kirmani, Salman

PY - 2015/3/6

Y1 - 2015/3/6

N2 - Whole-exome sequencing (WES) is being used clinically to diagnose rare Mendelian disorders, especially when standard tests have failed. The diagnostic yield from WES is reported to be ∼15-30%; however, data regarding the clinical utility and interpretative challenges from the clinician's perspective are lacking. Here, we present a series of the first 6 unselected consecutive cases seen over a period of 6 months where WES was employed in clinical labs via trio-based testing (proband and parents). While we do not discount the value of WES in the clinical setting, our cases and experience illustrate the significant clinical challenges of WES, even when a diagnosis may be achieved.

AB - Whole-exome sequencing (WES) is being used clinically to diagnose rare Mendelian disorders, especially when standard tests have failed. The diagnostic yield from WES is reported to be ∼15-30%; however, data regarding the clinical utility and interpretative challenges from the clinician's perspective are lacking. Here, we present a series of the first 6 unselected consecutive cases seen over a period of 6 months where WES was employed in clinical labs via trio-based testing (proband and parents). While we do not discount the value of WES in the clinical setting, our cases and experience illustrate the significant clinical challenges of WES, even when a diagnosis may be achieved.

KW - Diagnostic odyssey

KW - Schinzel-Giedion syndrome

KW - Whole-exome sequencing

UR - http://www.scopus.com/inward/record.url?scp=84924692296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924692296&partnerID=8YFLogxK

U2 - 10.1159/000371598

DO - 10.1159/000371598

M3 - Article

AN - SCOPUS:84924692296

VL - 6

SP - 23

EP - 31

JO - Molecular Syndromology

JF - Molecular Syndromology

SN - 1661-8769

IS - 1

ER -